What is it about?
Our fight against COVID19 continues: the predicted target (guanylate kinase) is robust against all currently threatening SARS-CoV-2 mutations in the alveolar macrophage.
Featured Image
Photo by CDC on Unsplash
Why is it important?
The COVID-19 pandemic is still threatening the world and effective treatments are still lacking.
Perspectives
This work could be an important step towards the development of an effective medical treatment against COVID-19.
Jun.-Prof. Dr. Andreas Dräger
Eberhard Karls Universitat Tubingen
Read the Original
This page is a summary of: Genome-Scale Metabolic Model of Infection with SARS-CoV-2 Mutants Confirms Guanylate Kinase as Robust Potential Antiviral Target, Genes, May 2021, MDPI AG,
DOI: 10.3390/genes12060796.
You can read the full text:
Resources
Contributors
The following have contributed to this page
